Latest Operational Update News

Page 28 of 31
Avenira Limited is advancing its Wonarah Phosphate Project with site mobilisation planned for mid-2025, backed by a $7.567 million capital injection from major shareholder Sichuan Hebang Technology. Operational milestones and regulatory approvals are progressing, positioning the company for first ore shipment in Q4.
Maxwell Dee
Maxwell Dee
30 Apr 2025
GBM Resources Limited reports significant progress in its exploration programs and asset sales for Q1 2025, including a key Mt Morgan divestment and ongoing farm-in developments at Mt Coolon.
Maxwell Dee
Maxwell Dee
30 Apr 2025
Duxton Farms reported a strategic property acquisition in the Northern Territory alongside a $38 million sale of its Kentucky aggregation, navigating challenging weather and mixed commodity prices in Q3 FY2025.
Ada Torres
Ada Torres
30 Apr 2025
Volt Group Limited reported a robust 26.8% revenue increase in Q1 FY25, driven by strong performances in its EcoQuip and Wescone divisions, alongside promising advances in its ATEN Waste Heat to Power technology.
Maxwell Dee
Maxwell Dee
30 Apr 2025
Impact Minerals Limited reported a solid cash position of A$3.75 million at quarter-end, supported by a recent equity raise that extends its funding runway to nearly four quarters despite ongoing exploration expenditures.
Maxwell Dee
Maxwell Dee
30 Apr 2025
Mirvac Group reported a surge in residential sales and advanced capital partnerships for major developments, reaffirming its FY25 earnings guidance amid strong leasing and occupancy across its portfolio.
Eva Park
Eva Park
30 Apr 2025
Stockland’s 3Q25 update highlights steady progress on its Waterloo Renewal Project and solid sales in masterplanned communities, supporting maintained FY25 earnings guidance.
Eva Park
Eva Park
30 Apr 2025
Native Mineral Resources Holdings Limited reported a $3.2 million net cash outflow from operations in Q1 2025 but strengthened its balance sheet with a $4.52 million capital raising post-quarter.
Maxwell Dee
Maxwell Dee
30 Apr 2025
Tryptamine Therapeutics has secured a landmark agreement with Swinburne University to initiate the first clinical trial of its IV-infused psilocin formulation TRP-8803 for Binge Eating Disorder, aiming to build on promising Phase 2a data.
Ada Torres
Ada Torres
30 Apr 2025
Harris Technology Group reported steady Q3 FY25 sales of $3.3 million alongside a modest operating cash outflow, while successfully raising $1.5 million to fuel expansion in refurbished electronics.
Logan Eniac
Logan Eniac
29 Apr 2025
Rent.com.au has successfully completed a $1.7 million entitlement issue, positioning itself to expand into loan funding under its RentBond brand while shoring up working capital.
Sophie Babbage
Sophie Babbage
29 Apr 2025
Lumos Diagnostics reported a 21% quarter-on-quarter revenue increase in Q3 FY25, driven by strong product sales and expanded development agreements. The company also secured Medicare coverage in key US regions and advanced its pivotal FebriDx CLIA waiver study with FDA submission expected by year-end.
Ada Torres
Ada Torres
29 Apr 2025